Anal High Grade Squamous Intraepithelial Lesion clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Sorry, in progress, not accepting new patients
This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
at UCSF
Our lead scientists for Anal High Grade Squamous Intraepithelial Lesion research studies include Joel Palefsky, MD.
Last updated: